Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Operating Expenses (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Operating Expenses for 12 consecutive years, with $69.5 million as the latest value for Q1 2026.

  • For Q1 2026, Operating Expenses rose 17.91% year-over-year to $69.5 million; the TTM value through Mar 2026 reached $268.7 million, up 16.47%, while the annual FY2025 figure was $258.1 million, 18.02% up from the prior year.
  • Operating Expenses hit $69.5 million in Q1 2026 for Wave Life Sciences, down from $73.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $73.7 million in Q4 2025 and bottomed at $39.2 million in Q3 2022.
  • Average Operating Expenses over 5 years is $52.6 million, with a median of $47.7 million recorded in 2023.
  • Year-over-year, Operating Expenses decreased 11.01% in 2022 and then increased 27.32% in 2024.
  • Wave Life Sciences' Operating Expenses stood at $44.8 million in 2022, then grew by 6.55% to $47.7 million in 2023, then rose by 27.32% to $60.8 million in 2024, then rose by 21.27% to $73.7 million in 2025, then decreased by 5.65% to $69.5 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $69.5 million, $73.7 million, and $64.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.